Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Heska Corp (NASDAQ:HSKA)

67.23
Delayed Data
As of Dec 05
 +1.97 / +3.02%
Today’s Change
26.26
Today|||52-Week Range
69.80
+73.81%
Year-to-Date
Pfizer (PFE) Presents Favorable Data on Leukemia Candidate
Dec 05 / Zacks.com - Paid Partner Content
Amicus Provides Regulatory Update on Fabry Disease Drug
Nov 29 / Zacks.com - Paid Partner Content
Pfizer Offers Positive Phase III Data on Pediatric Epilesy Drug
Dec 02 / Zacks.com - Paid Partner Content
Jazz Completes Patient Enrollment in JZP-110 Narcolepsy Trial
Nov 29 / Zacks.com - Paid Partner Content
AbbVie Crohn's Disease Drug Gets Orphan Drug Status in U.S.
Dec 01 / Zacks.com - Paid Partner Content
Glaxo (GSK) Files Regulatory Application for Shingrix in EU
Nov 28 / Zacks.com - Paid Partner Content
Ultragenyx (RARE) Reports Positive Phase II Study on UX007
Dec 01 / Zacks.com - Paid Partner Content
Merck's New Drugs, Cost Management to Fuel Growth in 2017
Nov 25 / Zacks.com - Paid Partner Content
Achillion, J&J to Initiate Phase IIb Study on HCV Combo
Dec 01 / Zacks.com - Paid Partner Content
OPKO Health (OPK) Launches Kidney Drug Rayaldee in U.S.
Nov 25 / Zacks.com - Paid Partner Content
Time to Focus on Heska (HSKA) for Strong Earnings Growth Potential
Nov 30 / Zacks.com - Paid Partner Content
Juno's ROCKET Study on Clinical Hold Again, Shares Down
Nov 24 / Zacks.com - Paid Partner Content
Valeant (VRX) Ups Sales Force to Support Xifaxan/Relistor
Nov 30 / Zacks.com - Paid Partner Content
Is Heska (HSKA) Stock a Solid Choice Right Now?
Nov 23 / Zacks.com - Paid Partner Content
Mallinckrodt (MNK) Tops Q4 Earnings on Solid Sales Growth
Nov 29 / Zacks.com - Paid Partner Content
Allergan's Fibristal Approved in Canada for Label Expansion
Nov 22 / Zacks.com - Paid Partner Content